Pharmacological Enhancement for Nocturnal Incontinence in Orthotopic Bladder Substitute

Summary

In this randomised trial, we hypothesised that mebeverine could enhance nocturnal continenece of Orthotopic Bladder Substitute (OBS) patients by decreasing the frequency and reduce maximum amplitude of uninhibited contractions of OBS ileum, and consequently it would increase the OBS capacity

Timeline

Start

2019-03-01

Primary completion

2020-03-01

Completion

2020-03-01

Drugs

Indications